List view / Grid view

Eli Lilly and Company

Filter the results

 

article

Antibody therapeutics for COVID-19

10 September 2020 | By

In 2019, the SARS-CoV-2 coronavirus sparked a global pandemic that is likely to continue into 2021. Effective therapeutics that treat the symptoms of the disease and prevent or treat the underlying viral infection are critically required. To meet this need, the global biopharmaceutical industry is evaluating over 50 monoclonal antibody…

news

Epidarex Capital launches Nodthera Limited

28 July 2016 | By Epidarex Capital

Epidarex Capital announces the launch of Nodthera Limited, a new biotech company focused on the discovery and development of novel inhibitors of the NLRP3 inflammasome...